First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma

Informazioni relative al progetto

CARE1

ID dell’accordo di sovvenzione: 101104801

DOI

10.3030/101104801

Data della firma CE 24 Aprile 2023

Data di avvio 1 Maggio 2023

Data di completamento 30 Aprile 2028

Finanziato da

• Health

Costo totale

€ 5 577 693,50

Contributo UE

€ 5 577 693,50

Coordinato da

INSTITUT GUSTAVE ROUSSY
France

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Documents, reports (10)

Status report - implementation of the digital PRO retrieval and patients monitoring platform
Conclusions of common annual meeting of the ‘Diagnosis and treatment’ cluster(1)

Conclusions of common annual meeting of the ‘Diagnosis and treatment’ cluster (1)

New QoL questionnaire implemented in CARE1 Pragmatic Clinical Trial
Initial common work plan for scientific collaboration under the ‘Diagnosis and treatment’ cluster
Communication and dissemination plan: Details on the dissemination strategy and action plan including analysis of stakeholder groups, identification of key events and activities
Project Management Plan (PMP): organisation, scope of work, Master Plan, Project Action List, risk register, including a project quality plan (PQP)
Educational material package 1
Standard operating procedure for local PDL1 assessment
First meeting of the PAB minutes
Policy brief formulating recommendations based on the research and innovation strand of the ‘Diagnosis and treatment’ annual cluster meeting (1)

Websites, patent fillings, videos etc. (1)

Visual identity, website and social media: Project branding, introductory project materials, video, infographics, logo are available, website is published and social media accounts operative

Pubblicazioni

Peer reviewed articles (1)

1717TiP CARE1 pragmatic clinical trial: First line randomised study platform to optimize treatment in patients with metastatic renal cell carcinoma

Autori: L. Albiges, C. Suarez Rodriguez, G. Procopio, A. Bex, V. Gruenwald, M. Schmidinger, B. Melichar, G.A. De Velasco Oria, C.D. Bergerot, R. Giles, R. Woodward, A.R. Ferreira, N. Rioux-Leclercq, J. Bonastre, M. Claveau, R. Flippot, B. Escudier, S. Foulon, T.B. Powles
Pubblicato in: Annals of Oncology, Numero 35, 2024, ISSN 0923-7534
Editore: Elsevier BV
DOI: 10.1016/j.annonc.2024.08.2128